Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

The city laid out a series of proposals to reduce cancer deaths by 20 percent ... intent on increasing residents’ life expectancy after a pandemic-era decline from which the city has not ...

But today, most people with lupus have a typical life expectancy with treatment ... to death include cardiovascular disease, kidney failure, and cancer. About 85 to 90% of people with lupus ...

Wade's experience gave him a new perspective on life ... Kidney cancer's details, causes, and treatments were also explained. From the basketball court to the surgery table.

In clinical trials, researchers didn’t measure life expectancy. Instead, they looked at progression-free survival. This is a period of time during which a person’s cancer doesn’t worsen.

Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic ... Why do people beat the average multiple myeloma life expectancy prognosis?

In 1999, the median overall survival (OS) reported by Motzer at the Memorial Sloan Kettering Cancer Center (MSKCC ... The results indicated no clinically meaningful reduction in life expectancy ...

5 China Standard Medical Information Research Center, Shenzhen, People’s Republic of China 6 Peking-Tsinghua Center for Life Sciences ... obstructive nephropathy, renal cancer, tubulointerstitial ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Case-Based Session: Management of ...

Adult patients admitted to a critical care unit will be screened for the presence of AKI, on the basis of either serum creatinine or urine output, as defined by the Kidney Disease Improving Global ...

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...